Abstract
Background
Nearly 60% of breast cancer cases in Mexico are in advanced stages. At our institution, concomitant preoperative chemoradiation is being used in patients with advanced breast cancer. In the present study, we evaluated the postoperative wound complications and risk factors associated.
Patients and methods
The study included breast cancer patients from January 2000 to December 2002 treated with concomitant preoperative chemoradiation and mastectomy. Wound complication rates were described along with a nested case–control analysis to evaluate risk factors for postoperative major wound complications.
Results
We evaluated 360 patients treated with preoperative chemoradiation. About 165 patients (45.8%) developed a wound complication (infection and/or flap necrosis); 60 (16.6%) patients had a surgical site infection (SSI) and 61 (16.9%), flap necrosis; 44 (12.2%) developed both complications, and 25 (6.9%) experienced late dehiscence after suture removal. Epidermolysis, seroma, and hematoma ocurred in 93 (25.8%), 80 (22.2%), and 12 patients (3.3%), respectively. Case–control analysis was conducted in 335 patients. After logistic regression analysis, the sole variable found associated with SSI and/or flap necrosis was epidermolysis (OR = 8.81, 95% CI = 4.52–17.18). Although not significant and of lesser magnitude, adjusted risk estimates of overweight, age >50 years, and type of mastectomy showed the same trend.
Conclusions
Postoperative wound complications were not different from those observed in non-radiated patients, but its rate was higher. Epidermolysis was associated with SSI and/or flap necrosis. Careful surgical technique should be encouraged.
Similar content being viewed by others
References
Registro Histopatológico de Neoplasias en México (RHPNM) 2000. Grupos etáreos, DGE/SSA
Ramírez-Ugalde MT, Alvarado A, Lara FU, Cantú D, Gamboa C, Alanis P, Fuentes-Alburo A, Morales F, Robles C, Zinser JW: Preoperative chemoradiosensitizing with gemcitabine in neoadjuvant chemoresistant locally advanced breast cancer (LABC) patients. Instituto Nacional de Cancerología, Mexico City, Mexico. American Society of Clinical Oncology (ASCO) 2003, Thirty-ninth Annual Meeting, Chigago, Illinois, USA, May 31–June 3, 2003. Abstract No. 160
Rotstein C, Ferguson R, Cummings KM, Piedmonte MR, Lucey J, Banish A, Determinants of clean surgical wound infections for breast procedures at an oncology center Infect Control Hosp Epidemiol 1992 13 207–214
Broadwater JR, Edwards MJ, Kuglen C, Hortobagyi GN, Ames FC, Balch CM, Mastectomy following preoperative chemotherapy: strict operative criteria control operative morbidity Ann Surg 1991 213 126–129
Terrel GS, Singer JA, Axillary versus combined axillary and pectoral drainage after modified radical mastectomy Surg Gynecol Obstet 1991 175 437–440
Canavese G, Catturich A, Vecchio C, Gipponi M, Tomei D, Sertoli MR, Repetto L, Badellino F, Surgical complications related to peri-operative adjuvant chemotherapy in breast cancer: results of a prospective, controlled randomized clinical trial Eur J Surg Oncol 1997 23 10–12
Furey PC, MacGillivray DC, Castiglione CL, Allen L, Wound complications in patients receiving adjuvant chemotherapy after mastectomy and immediate breast reconstruction for breast cancer J Surg Oncol 1994 55 194–197
Lefebvre D, Penel N, Deberles MF, Fournier C, Incidence et facteurs de risqué d’infections du site opératoire en chirurgie carcinologique mamaire Presse Med2000 29 1927–1932
Vilar-Compte D, Jacquemin B, Robles-Vidal C, Volkow P, Surgical site infections in breast surgery: case–control study World J Surg2004 28 242–246
Horan TC, Gaynes RP, Martone WJ, William RJ, Emori TG, CDC Definitions of nosocomial surgical site infections, 1992: a modification of CDC definitions of surgical wound infections Infect Control Hosp Epidemiol 1992 13 606–608
Badr el Din A, Coibion M, Guenier C, Nogaret JM, Lorent I, Van-Houtte P, Tueni E, Mattheim W, Local postoperative morbidity following pre-operative irradiation in locally advanced breast cancer Eur J Surg Oncol1989 15 486–489
Sauter ER, Eisenberg BL, Hoffman JP, Ottery FD, Boraas MC, Goldstein LJ, Goldstein LJ, Solin LJ, Postmastectomy morbidity after combination preoperative irradiation and chemotherapy for locally advanced breast cancer World J Surg1993 17 237–241
Skinner KA, Dunnington G, Silberman H, Florentine B, Spicer D, Formenti SC, Preoperative 5-Fluorouracil and radiation therapy for locally advanced breast cancer Am J Surg1997 174 705–708
Huang E, Mcneese MD, Strom EA, Perkins GH, Katz A, Hortobagyi GN, Valero V, Kuerer HM, Singletary SE, Hunt KK, Budzar AU, Buchholz TA, Locoregional treatment outcomes for inoperable anthracycline-resistant breast cancer Int J Radiat Oncol Biol Phys 2000 2 53 1225–1233
Volkow P, Vazquez C, Tellez O, Aguilar C, Barrera L, Rodriguez E, Vilar-Compte D, Zinser J, Calderón E, Pérez-Padilla JR, Mohar A, Polyurethane II catheter as long-indwelling intravenous catheter in patients with cancer Am J Infect Control 2003 31 392–396
Mathes SJ, Alexander J, Radiation injury Surg Oncol Clin North Am 1996 5 809–824
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Ruvalcaba-Limón, E., Robles-Vidal, C., Poitevin-Chacón, A. et al. Complications after breast cancer surgery in patients treated with concomitant preoperative chemoradiation: a case–control analysis. Breast Cancer Res Treat 95, 147–152 (2006). https://doi.org/10.1007/s10549-005-9058-y
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10549-005-9058-y